Auransa, Inc., an artificial intelligence (AI) company developing precision medicines in areas of unmet medical needs, and Polaris Quantum Biotech (Polarisqb), a quantum computing-based drug design company, announced exciting progress in a joint project to tackle triple-negative breast cancer.